Clinical Trial Update: Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of capecitabine combined with 131I-huA33 in metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• 131I-huA33 (131I-huA33)
• Capecitabine (capecitabine)

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Colorectal Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2022-01-11